ALN-SOD, an experimental RNA-based therapy being developed for a genetic subtype of amyotrophic lateral sclerosis (ALS) ...

For Emmy award-winning host and New York Times bestselling author Tabitha Brown, joy, gratitude, and hope have guided her ...

An experimental implantable device from Precision Neuroscience enabled computers to decode brain signals to predict movement ...

Over the years with ALS, Todd ended up expressing his creativity in other ways. When he still had a strong voice, he preached ...

New research indicates that people with diabetes may have a lower risk of developing ALS compared to those without diabetes.

Higher overall physical activity was associated with a lower risk of developing ALS. Genetic risk factors may influence how ...

Stem cell therapies are generally safe, well tolerated, and show preliminary potential in slowing functional decline for ...

The ALS Nexus conference unites researchers, clinicians, caregivers, and patients to collaborate on changing the future of ...

While scrolling through social media the other day, I came across a question that stopped me in my tracks: How has having ALS ...

The ALS Association has awarded Mitochon Pharmaceuticals a $1 million grant to support a Phase 2 clinical trial testing the company’s experimental therapy MP-101 in people with amyotrophic lateral ...

Nine years ago, and seven years into my husband Todd’s ALS journey, we were still trying our best to get out and have a normal life. That fall, our 8-year-old son came home from school with a flyer ...

Researchers developed a modified frailty index to help identify individuals at higher risk of developing ALS. Key indicators included falls, whole-body pain, long-standing illness or disability, ...